Metraipolis › archive › dc_6b027f73da94
Real-World Outcomes of Baricitinib Monotherapy Versus csDMARD Combination Therapy in Rheumatoid Arthritis: A SingleCenter Retrospective Analysis of Efficacy,… — Europe PMC PMID:40963337
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40963337
- DOI
- 10.5152/archrheumatol.2025.11131
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T05:23:37.639Z
- SHA-256 of the archived text
4031945095988b6d1d5ef25df0c2984fbcc096592142ed50f2e6d1b890964fe4- Stable URL of this page
https://metraipolis.com/documento/dc_6b027f73da94
How to cite
Real-World Outcomes of Baricitinib Monotherapy Versus csDMARD Combination Therapy in Rheumatoid Arthritis: A SingleCenter Retrospective Analysis of Efficacy,… — Europe PMC PMID:40963337 — Europe PMC (en), https://europepmc.org/article/MED/40963337 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6b027f73da94 (Metraipolis archive dc_6b027f73da94, sha256 4031945095988b6d1d5ef25df0c2984fbcc096592142ed50f2e6d1b890964fe4)
BibTeX
@misc{dc6b027f73da94,
title = {Real-World Outcomes of Baricitinib Monotherapy Versus csDMARD Combination Therapy in Rheumatoid Arthritis: A SingleCenter Retrospective Analysis of Efficacy,… — Europe PMC PMID:40963337},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40963337},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6b027f73da94; sha256 4031945095988b6d1d5ef25df0c2984fbcc096592142ed50f2e6d1b890964fe4},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40963337. Agents can read the archived copy with the MCP tool read_document.